↓ Skip to main content

Dove Medical Press

Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications

Overview of attention for article published in OncoTargets and therapy, January 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
googleplus
1 Google+ user

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
72 Mendeley
Title
Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications
Published in
OncoTargets and therapy, January 2014
DOI 10.2147/ott.s52600
Pubmed ID
Authors

Zsuzsanna Suba

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Egypt 1 1%
Unknown 71 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 17%
Student > Bachelor 11 15%
Student > Ph. D. Student 11 15%
Other 6 8%
Researcher 4 6%
Other 9 13%
Unknown 19 26%
Readers by discipline Count As %
Medicine and Dentistry 21 29%
Agricultural and Biological Sciences 9 13%
Biochemistry, Genetics and Molecular Biology 7 10%
Nursing and Health Professions 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Other 7 10%
Unknown 18 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#15,168,167
of 25,371,288 outputs
Outputs from OncoTargets and therapy
#777
of 3,016 outputs
Outputs of similar age
#176,711
of 319,271 outputs
Outputs of similar age from OncoTargets and therapy
#12
of 23 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,271 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.